The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
1
Department of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan
2
Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan
*
Author to whom correspondence should be addressed.
†
Members are listed in the Acknowledgments.
Int. J. Mol. Sci. 2020, 21(11), 3863; https://doi.org/10.3390/ijms21113863
Received: 18 April 2020 / Revised: 22 May 2020 / Accepted: 24 May 2020 / Published: 29 May 2020
(This article belongs to the Special Issue Diabetic Liver Disease)
Nonalcoholic fatty liver disease (NAFLD) consists of the entire spectrum of fatty liver disease in patients without significant alcohol consumption, ranging from nonalcoholic fatty liver (NAFL) to nonalcoholic steatohepatitis (NASH) to cirrhosis, with NASH recently shown as an important cause of hepatocellular carcinoma (HCC). There is a close relationship between insulin resistance (IR) and NAFLD, with a five-fold higher prevalence of NAFLD in patients with type 2 diabetes (T2DM) compared to that in patients without T2DM. IR is involved in the progression of disease conditions such as steatosis and NASH, as well as hepatic fibrosis progression. The mechanisms underlying these processes involve genetic factors, hepatic fat accumulation, alterations in energy metabolism, and inflammatory signals derived from various cell types including immune cells. In NASH-associated fibrosis, the principal cell type responsible for extracellular matrix production is the hepatic stellate cell (HSC). HSC activation by IR involves “direct” and “indirect” pathways. This review will describe the molecular mechanisms of inflammation and hepatic fibrosis in IR, the relationship between T2DM and hepatic fibrosis, and the relationship between T2DM and HCC in patients with NAFLD.
View Full-Text
Keywords:
hepatic fibrosis; insulin resistance; inflammation; stellate cell; hepatocellular carcinoma
▼
Show Figures
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Fujii, H.; Kawada, N.; Japan Study Group of NAFLD. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci. 2020, 21, 3863. https://doi.org/10.3390/ijms21113863
AMA Style
Fujii H, Kawada N, Japan Study Group of NAFLD. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences. 2020; 21(11):3863. https://doi.org/10.3390/ijms21113863
Chicago/Turabian StyleFujii, Hideki; Kawada, Norifumi; Japan Study Group of NAFLD. 2020. "The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease" Int. J. Mol. Sci. 21, no. 11: 3863. https://doi.org/10.3390/ijms21113863
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
Search more from Scilit